What is the ROE (Return on Equity) of Byhealth Co this year?
The ROE of Byhealth Co this year is 0.14 undefined.
Byhealth Co ROE 2024
Byhealth Co ROE
0.14
Ticker
300146.SZ
ISIN
CNE100000Y84
In 2024, Byhealth Co's return on equity (ROE) was 0.14, a 10.75% increase from the 0.13 ROE in the previous year.
Byhealth Co Aktienanalyse
What does Byhealth Co do?
Byhealth Co Ltd is a company that specializes in the manufacture and sale of dietary supplements and health products. The company was founded in 1998 in Guangzhou, China. The founder of Byhealth, Mr. Liang Guangwei, has early on specialized in the production of high-quality health products and cosmetics. As a result, Byhealth quickly became a leading company in the dietary supplement industry. The company enjoys a very good reputation, particularly in Asia, and has received multiple awards. The goal of Byhealth is to offer high-quality dietary supplements and health products that support the health and well-being of customers. The company relies on its own research and development, which guarantees a high quality of the products. Byhealth distributes its products worldwide, particularly in Asia, Europe, and North America. The company works closely with distribution partners to reach a wide customer base. To achieve this, Byhealth has developed a variety of product lines tailored to different customer needs. These include products to support the immune system, digestion, sleep, skin, metabolism, and weight loss. Byhealth pays special attention to its product line Revotropix, which is among the most well-known and popular in the industry. The products contain a variety of plant-based and natural ingredients that are supposed to alleviate symptoms of stress, pain, and depression. The products are available in various forms, such as capsules or powder. Another important area is weight loss products, which are intended to help customers control and reduce their weight. These include fat-binding tablets and products that stimulate metabolism. Byhealth strictly adheres to the highest quality standards in the production of its products. All products are produced in accordance with Good Manufacturing Practice (GMP) and other international standards. The company uses only natural ingredients to ensure that all products are safe and effective. As an innovative company, Byhealth also relies on new technologies and trends to further improve its products. For example, the company uses the latest technology for the extraction of natural ingredients to ensure a higher efficacy and purity of its products. Overall, Byhealth has earned an excellent reputation in the industry with its high-quality dietary supplements and health products. Through its research and development and the use of state-of-the-art production methods, Byhealth is able to offer a wide range of health products that help customers improve their health and well-being. Byhealth Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Byhealth Co's Return on Equity (ROE)
Byhealth Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Byhealth Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Byhealth Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Byhealth Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Byhealth Co stock
How has the Return on Equity (ROE) of Byhealth Co developed compared to the previous year?
The ROE of Byhealth Co has increased by 10.75% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Byhealth Co?
A high ROE indicates that Byhealth Co generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Byhealth Co?
A low ROE can indicate that Byhealth Co is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Byhealth Co affect the company?
A change in ROE (Return on Equity) of Byhealth Co can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Byhealth Co?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Byhealth Co?
Some factors that can influence Byhealth Co's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Byhealth Co pay?
Over the past 12 months, Byhealth Co paid a dividend of 0.18 CNY . This corresponds to a dividend yield of about 1.21 %. For the coming 12 months, Byhealth Co is expected to pay a dividend of 0.19 CNY.
What is the dividend yield of Byhealth Co?
The current dividend yield of Byhealth Co is 1.21 %.
When does Byhealth Co pay dividends?
Byhealth Co pays a quarterly dividend. This is distributed in the months of May, May, May, May.
How secure is the dividend of Byhealth Co?
Byhealth Co paid dividends every year for the past 16 years.
What is the dividend of Byhealth Co?
For the upcoming 12 months, dividends amounting to 0.19 CNY are expected. This corresponds to a dividend yield of 1.25 %.
In which sector is Byhealth Co located?
Byhealth Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Byhealth Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Byhealth Co from 4/22/2024 amounting to 0.9 CNY, you needed to have the stock in your portfolio before the ex-date on 4/22/2024.
When did Byhealth Co pay the last dividend?
The last dividend was paid out on 4/22/2024.
What was the dividend of Byhealth Co in the year 2023?
In the year 2023, Byhealth Co distributed 0.7 CNY as dividends.
In which currency does Byhealth Co pay out the dividend?
The dividends of Byhealth Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Byhealth Co
Our stock analysis for Byhealth Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Byhealth Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.